Tau PNU Medical Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Tau PNU Medical General Information


Developer of trans-catheter technology designed to treat heart diseases. The company's technology designs a coronary sinus and tricuspid valve protective device (CSTV) for the treatment of functional mitral regurgitation (FMR) associated with heart failure and the preclinical outcomes in the swine samples, enabling patients to get an effective heart therapy and ensure a healthy life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Monitoring Equipment
Primary Office
  • 2,Busandaehak-ro 63beon-gil, Geumjeong-gu
  • Institute for Research and industry cooperation, 206
  • Busan, 609-836
  • South Korea
+82 000-000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tau PNU Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2014 Completed Startup
To view Tau PNU Medical’s complete valuation and funding history, request access »

Tau PNU Medical Executive Team (1)

Name Title Board Seat Contact Info
Peter Park Chief Executive Officer
To view Tau PNU Medical’s complete executive team members history, request access »

Tau PNU Medical Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Stonebridge Capital Venture Capital Minority 000 0000 000000 0
To view Tau PNU Medical’s complete investors history, request access »